Date: August 13 & 14 2013
executives from more than 75 prominent public and private companies across sectors including
biotechnology, medical devices, emerging pharmaceuticals, healthcare services, managed care, medical
diagnostics and life sciences tools.conference calling
The following companies presented at the Wedbush Life Sciences Management Access Conference: Alexza, Algeta, Amicus Therapeutics, Anacor Pharmaceuticals, Ariosa Diagnostics, Avanir Pharmaceuticals, AxoGen, Biodel, Cadence Pharmaceuticals, Bluebird Bio, Cara Therapeutics, Cardica, Catabasis Pharmaceuticals, CellScape, Cepheid, Cerus, Chelsea Therapeutics, Civitas Therapeutics, CONMED Corporation, Coronado Biosciences, Curis, Delcath Systems, diaDexus, Durata Therapeutics, EndoStim, Emergent BioSolutions, Epizyme, Endocyte, Forma Therapeutics, Genocea, Gentium S.p.A., Good Start Genetics, GTx, Inc., Illumina, ImmunoGen, Insmed, Intercept Pharmaceuticals, IRIDEX, KellBenX, Kindred Bio, Lexicon Pharmaceuticals, Medivation, MEI Pharma, Metabolon, Natera, Novavax, NPS Pharmaceuticals, Ohr Pharmaceutical, Omeros Corp., OncoGenex Pharmaceuticals, Oncolytics Biotech, Oncothyreon, OvaScience, Pacira Pharmaceuticals, Palatin Technologies, Peregrine Pharmaceuticals, Prosensa, Prothena Corporation, PTC Therapeutics, Receptos, Regado Biosciences, Relypsa, Sangamo BioSciences, Sarepta Therapeutics, Sequenom, SIGA Technologies, Spectral Diagnostics, Spectrum Pharmaceuticals, Stemline Therapeutics, Summit PLC, Sunesis Pharmaceuticals, Synageva Biopharma, Tekmira Pharmaceuticals, Ultragenyx, Verastem, Xencor, Xoma and Zalicus.
Access Transcripts of these webcast presentations here
Tidak ada komentar:
Posting Komentar